Pazzallo, Switzerland

Enrico Braglia

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Biasca, CH (2006)
  • Pazzallo, CH (2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Enrico Braglia: Innovator in Pharmaceutical Formulations

Introduction

Enrico Braglia is a notable inventor based in Pazzallo, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of liquid formulations for medical use. With a total of 4 patents, his work has had a meaningful impact on the treatment of patients undergoing chemotherapy and radiotherapy.

Latest Patents

One of his latest patents focuses on liquid pharmaceutical formulations of palonosetron. This invention relates to shelf-stable liquid formulations designed to reduce chemotherapy and radiotherapy-induced emesis. The formulations are particularly useful in the preparation of both intravenous and oral liquid medicaments. This innovation is crucial for improving patient comfort and treatment efficacy.

Career Highlights

Throughout his career, Enrico Braglia has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Helsinn Healthcare SA and Roche Palo Alto LLC. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Enrico has collaborated with several professionals in his field, including Riccardo Braglia and Giorgio Calderari. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Enrico Braglia stands out as an influential inventor in the pharmaceutical sector, with a focus on improving patient care through innovative formulations. His contributions continue to shape the landscape of medical treatments, making a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…